Open access peer-reviewed Edited Volume
Current Clinical Management and Future Therapeutics
19827 Total Chapter Downloads
14 Crossref Citations
14 Web of Science Citations
24 Dimensions Citations
chapters | Downloads | |
---|---|---|
Open access peer-reviewed 1. Melanoma — Epidemiology, Risk Factors, and the Role of Adaptive PigmentationBy Erin M. Wolf Horrell, Kalin Wilson and John A. D’Orazio | 1665 | |
Open access peer-reviewed 2. Acral Melanoma — A Distinct Molecular and Clinical SubtypeBy R. Barra-Martínez, N.E. Herrera-González, F. Fernández –Ramírez and L.A. Torres | 1283 | |
Open access peer-reviewed 3. Signaling Pathways Altered During the Metastatic Progression of MelanomaBy Ana Carolina Monteiro, Mariana Toricelli and Miriam Galvonas Jasiulionis | 1275 | |
Open access peer-reviewed 4. Surgery and Staging of MelanomaBy Rolland Gyulai, Zsolt Kádár and Zsuzsanna Lengyel | 1827 | |
Open access peer-reviewed 5. Current Surgical Management of Acral Lentiginous MelanomaBy Yasuhiro Nakamura, Yukiko Teramoto, Sayuri Sato and Akifumi Yamamoto | 1738 | |
Open access peer-reviewed 6. Changing Perceptions of Lymphadenectomy and Sentinel Lymph Node Biopsy in MelanomaBy Antonio Sommariva, Camilla Cona and Carlo Riccardo Rossi | 1268 | |
Open access peer-reviewed 7. Current Insights Into Canine Cutaneous Melanocytic Tumours DiagnosisBy Luis Resende, Joana Moreira, Justina Prada, Felisbina Luisa Queiroga and Isabel Pires | 2243 | |
Open access peer-reviewed 8. Emerging Drug Combination Approaches in Melanoma TherapyBy Jin Wang, Duane D. Miller and Wei Li | 1269 | |
Open access peer-reviewed 9. New Insights in Cutaneous Melanoma Immune-Therapy — Tackling Immune-Suppression and Specific Anti-Tumoral ResponseBy Monica Neagu and Carolina Constantin | 1130 | |
Open access peer-reviewed 10. Can Redirected T Cells Outsmart Aggressive Melanoma? The Promise and Challenge of Adoptive Cell TherapyBy Jennifer Makalowski and Hinrich Abken | 1189 | |
Open access peer-reviewed 11. Toxicities of New Drugs for Melanoma Treatment and their ManagementBy Paola Savoia and Paolo Fava | 1219 | |
Open access peer-reviewed 12. Autotaxin – An Enzymatic Augmenter of Malignant Progression Linked to InflammationBy David N. Brindley, Matthew G.K. Benesch and Mandi M. Murph | 1403 | |
Open access peer-reviewed 13. RAGE and Its Ligands in MelanomaBy Estelle Leclerc | 1138 | |
Open access peer-reviewed 14. Gangliosides and Antigangliosides in Malignant MelanomaBy Corina-Daniela Ene (Nicolae) and Ilinca Nicolae | 1181 |
All IntechOpen contributors are offered special discounts starting at 40% OFF available through your personal dashboard
Login and purchase